Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Imunon, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 19 | 26 | +7 |
| Shares | 342.8K | 2.21M | +1.87M (+544.7%) |
| Value | $359.9K | $1.76M | +$1.40M (+389.4%) |
New holders (8)
Institutions that held Imunon, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 900,000 | $720.0K | 5.54% |
| Wells Fargo & Company | 41,823 | $33.5K | 0.00% |
| Virtu Financial LLC | 41,073 | $33.0K | 0.00% |
| Two Sigma Investments, LP | 29,578 | $23.7K | 0.00% |
| Baader Bank INC | 21,583 | $10.7K | 0.00% |
| Two Sigma Securities, LLC | 12,916 | $10.3K | 0.00% |
| Riverview Capital Advisers, LLC | 11,715 | $9.37K | 0.00% |
| Citigroup Inc | 11,577 | $9.26K | 0.00% |
Sold out (1)
Institutions that held Imunon, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Van Hulzen Asset Management, LLC | 10,266 | $10.8K |